Moderna, Inc. (MRNA)
138.89
-6.24
(-4.30%)
USD |
NASDAQ |
Aug 24, 16:00
139.00
+0.11
(+0.08%)
After-Hours: 20:00
Moderna Total Return Level : 138.89 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 138.89 |
| August 21, 2026 | 145.13 |
| August 20, 2026 | 133.32 |
| August 19, 2026 | 174.38 |
| August 18, 2026 | 62.96 |
| August 17, 2026 | 64.46 |
| August 14, 2026 | 63.32 |
| August 13, 2026 | 63.65 |
| August 12, 2026 | 63.67 |
| August 11, 2026 | 60.57 |
| August 10, 2026 | 59.81 |
| August 07, 2026 | 59.17 |
| August 06, 2026 | 53.86 |
| August 05, 2026 | 56.26 |
| August 04, 2026 | 56.99 |
| August 03, 2026 | 55.14 |
| July 31, 2026 | 54.82 |
| July 30, 2026 | 57.92 |
| July 29, 2026 | 54.49 |
| July 28, 2026 | 55.80 |
| July 27, 2026 | 55.63 |
| July 24, 2026 | 54.07 |
| July 23, 2026 | 57.02 |
| July 22, 2026 | 58.07 |
| July 21, 2026 | 59.66 |
| Date | Value |
|---|---|
| July 20, 2026 | 59.49 |
| July 17, 2026 | 61.82 |
| July 16, 2026 | 63.15 |
| July 15, 2026 | 68.28 |
| July 14, 2026 | 67.44 |
| July 13, 2026 | 67.01 |
| July 10, 2026 | 68.27 |
| July 09, 2026 | 76.56 |
| July 08, 2026 | 73.80 |
| July 07, 2026 | 79.77 |
| July 06, 2026 | 81.80 |
| July 02, 2026 | 79.76 |
| July 01, 2026 | 72.50 |
| June 30, 2026 | 70.03 |
| June 29, 2026 | 69.70 |
| June 26, 2026 | 67.27 |
| June 25, 2026 | 59.75 |
| June 24, 2026 | 60.42 |
| June 23, 2026 | 61.00 |
| June 22, 2026 | 59.34 |
| June 18, 2026 | 63.96 |
| June 17, 2026 | 61.80 |
| June 16, 2026 | 55.40 |
| June 15, 2026 | 52.13 |
| June 12, 2026 | 49.91 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| BioNTech SE | 114.34 |
| Kailera Therapeutics, Inc. | 16.54 |
| Sarepta Therapeutics, Inc. | 18.13 |
| Replimune Group, Inc. | 14.71 |
| Intellia Therapeutics, Inc. | 12.56 |